Predictive Medicine

Cardio Diagnostics Advances Personalized Heart Care Through AI and Epigenetics
Cardio Diagnostics Holdings is leveraging AI, epigenetics, and genetic insights to shift cardiovascular care from reactive treatment to predictive prevention, addressing heart disease as the leading cause of death worldwide.
May 18, 2026

DeLorean AI CEO Shares Insights on Predictive Medicine and the Future of Healthcare AI
Dr. Severence MacLaughlin, CEO of DeLorean AI, discusses the company's journey in predictive healthcare, the importance of real ROI in AI, and the future of predictive medicine.
August 6, 2025